Structural modifications of HDL and functional consequences.
about
Homocysteine-lowering interventions for preventing cardiovascular eventsHomocysteine-lowering interventions for preventing cardiovascular eventsHomocysteine lowering interventions for preventing cardiovascular eventsBeneficial effect of low ethanol intake on the cardiovascular system: possible biochemical mechanismsDecreased serum apolipoprotein A1 levels are associated with poor survival and systemic inflammatory response in colorectal cancer.Dysfunctional, pro-inflammatory HDL directly upregulates monocyte PDGFRβ, chemotaxis and TNFα production.Anti-oxidant properties of high-density lipoprotein and atherosclerosisCarotid intima media thickness and low high-density lipoprotein (HDL) in South Asian immigrants: could dysfunctional HDL be the missing link?Oxidized high-density lipoprotein impairs endothelial progenitor cells' function by activation of CD36-MAPK-TSP-1 pathwaysAssociation between cholesterol intake and pancreatic cancer risk: evidence from a meta-analysisSimultaneous transfer of cholesterol, triglycerides, and phospholipids to high-density lipoprotein in aging subjects with or without coronary artery diseaseAcrolein impairs the cholesterol transport functions of high density lipoproteins.Oxidized low-density lipoprotein.Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndromeAltered inflammation, paraoxonase-1 activity and HDL physicochemical properties in obese humans with and without Prader-Willi syndrome.Dietary intakes of carotenoids and other nutrients in the risk of nasopharyngeal carcinoma: a case-control study in ItalyEgg intake and bladder cancer risk: A meta-analysis.Pharmacogenomic application of the haptoglobin genotype in the treatment of HDL dysfunctionPrognostic Value of Elevated Homocysteine Levels in Korean Patients with Coronary Artery Disease: A Propensity Score Matched Analysis.Advanced glycation and lipoxidation end products--amplifiers of inflammation: the role of food.There is no relationship between Paraoxonase serum level activity in women with endometriosis and the stage of the disease: an observational study.High-density lipoprotein: a fall from grace?High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular diseaseCholesterol, lipoproteins, and breast cancer risk in African American women.Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus.Plasma and Aorta Biochemistry and MMPs Activities in Female Rabbit Fed Methionine Enriched Diet and Their Offspring.Catalytic antioxidant therapy by metallodrugs: lessons from metallocorroles.Emerging role of post-translational modifications in chronic kidney disease and cardiovascular disease.ApoA1 and ApoA1-specific self-antibodies in cardiovascular disease.Oxidized high density lipoprotein induces macrophage apoptosis via toll-like receptor 4-dependent CHOP pathway.CD36 in chronic kidney disease: novel insights and therapeutic opportunities.Consequences of Advanced Glycation End Products Accumulation in Chronic Kidney Disease and Clinical Usefulness of Their Assessment Using a Non-invasive Technique - Skin Autofluorescence.HDL-paraoxonase and membrane lipid peroxidation: a comparison between healthy and obese subjects.[Lipid transfer to HDl in women with type 1 diabetes].Alteration of high-density lipoprotein functionality in Alzheimer's disease patients.Gender related differences in paraoxonase 1 response to high-fat diet-induced oxidative stress.Consumption of high-dose vitamin C (1250 mg per day) enhances functional and structural properties of serum lipoprotein to improve anti-oxidant, anti-atherosclerotic, and anti-aging effects via regulation of anti-inflammatory microRNA.Lactonase Activity and Lipoprotein-Phospholipase A2 as Possible Novel Serum Biomarkers for the Differential Diagnosis of Autism Spectrum Disorders and Rett Syndrome: Results from a Pilot Study.Paraoxonase, arylesterase and lactonase activities of paraoxonase-1 (PON1) in obese and severely obese women.
P2860
Q24186605-B6BAE372-5EA1-4961-8816-5E3D2B89C931Q24201783-A146D8B2-9B18-4468-ADAC-EA8DD1923DFCQ24239981-90F10559-C744-41AA-89C7-E873895B9823Q30360076-2E5C7703-E4F6-4F72-B069-DC6004740452Q33905987-42949F2A-9E08-4854-8CC0-4B00E68DC080Q34137840-3854B7D9-C747-4B86-A2D1-808B57AF8CCEQ34440172-EE70C406-20D9-4E9B-A4DE-1A48CE2297BFQ34466725-0B3F4A0C-2AAC-4BD0-92C3-B2FFE53DCBB8Q34981709-6ADAC02A-F9AD-4410-A885-1E549A00EAC8Q35045995-F521A1C3-CA1E-4BE4-A0A8-6F4C3B8C03E1Q35188359-831C952A-6F11-4762-AE39-A1DFC8657F7BQ35301213-83ED26C5-703F-4DFA-9FF2-7EC9C6D93196Q35860737-072224D5-E66D-4F95-812B-5E2CAC038341Q36176111-62450A81-3B3C-4E7C-862B-2C2308B0D641Q36179991-62B60B47-5604-4C69-B293-389383E050EAQ36385274-0864AEA4-73E4-4CAB-820A-50CB35F9F686Q36385364-A2F06D96-D678-419B-B466-7B044E0EC128Q36441429-2AAFBBBB-EBCC-426D-9698-348009F6DB24Q36723469-EFB45CA9-3197-4131-BF59-EE04F3E0314DQ36915810-1E9D010C-F436-4F3A-A9D2-1705EDE9FFF5Q36996548-B360EC6C-0B96-45E6-8C4C-C9E44B326A8DQ37209767-BA075ED9-62C5-48BC-98D3-69A08E6AE6DCQ37305341-6F8DF5D5-4CEF-4808-A6FD-A0696C0BDA3EQ37314852-99F6A1F1-35EC-454C-8C6E-A3F6F997ADD0Q37355913-F48C7C65-3FF2-42EA-BBA2-4002055AE605Q37367326-AA039E59-07C1-4CC1-B30F-C69B01A81295Q37590874-6C04D1CF-89E2-4644-8FC4-7FCDAB18C654Q38348969-5B800FD9-4165-4040-B63E-0711E10A763AQ38415749-14952840-AABF-4A50-9507-CEEB228B4C82Q38835289-5C114122-0D8E-40DE-BDA2-37E4D9B99900Q39147502-2D1F52F4-5BDD-4A3A-B8C6-90D2EA7DE1C6Q41935783-91167619-CF26-4227-A9DF-D765DE76AB27Q42120056-884C908D-EEF0-407F-A601-9CB3C8FB752CQ43260384-DEA926C5-DA55-49E3-BA5B-C8DB2CF013B7Q46060806-E7D0AD53-16DD-4CD7-9069-7CB97A124955Q46387256-C8144346-6CF9-4ADC-ADB6-117F26C31E5DQ46417007-9DA14279-1124-45AA-9B92-C86C312650AEQ46675528-D8ABBB00-89C2-4460-BDAE-710D40F1807FQ47291057-5E874414-A365-4340-A2DB-4746882C3AC1Q47371373-9C35F8CB-95E4-48A1-86C7-34F1B2C89061
P2860
Structural modifications of HDL and functional consequences.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Structural modifications of HDL and functional consequences.
@ast
Structural modifications of HDL and functional consequences.
@en
type
label
Structural modifications of HDL and functional consequences.
@ast
Structural modifications of HDL and functional consequences.
@en
prefLabel
Structural modifications of HDL and functional consequences.
@ast
Structural modifications of HDL and functional consequences.
@en
P2093
P1433
P1476
Structural modifications of HDL and functional consequences.
@en
P2093
Anne Nègre-Salvayre
Gianna Ferretti
Giovanna Curatola
Nicole Dousset
Robert Salvayre
Tiziana Bacchetti
P356
10.1016/J.ATHEROSCLEROSIS.2005.08.008
P577
2005-09-12T00:00:00Z